GX Sciences to Offer Patia Type 2 Diabetes Risk Test in US

Jul 24, 2019

|

NEW YORK — Spanish diabetes testing firm Patia said today that it has signed an agreement to market its type 2 diabetes (T2D) risk test in the US through GX Sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

GX Sciences to Offer Patia Type 2 Diabetes Risk Test in US

To read the full story....

Breaking News

Biodesix, Streck Partner on Cancer CDx Sample Collection

IDbyDNA Raises $20M in Series B Financing

Novacyt Posts 4 Percent Drop in Preliminary 2019 Revenues

Inex Inks Taiwan Distribution Deal for OvaCis Test

FDA Clears Beckman Coulter's Procalcitonin Assay

Co-Diagnostics Closes $5M Offering of Shares

Featured White Papers

Development of a Novel Multiplex Assay: A Partnership Case Study

What's Popular?

CDC Provides Test Protocol for Novel Coronavirus, Preps Kits for Local Use

Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

IDbyDNA Raises $20M in Series B Financing

Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

Sponsorships